75TiP Open-label, phase II study of tusamitamab ravtansine (SAR408701) in combination with pembrolizumab and with pembrolizumab + platinum-based chemotherapy +/− pemetrexed in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05)
| Autor: | L. Paz-Ares, S. Parakh, J. Park, C. Rojas, F. Orlandi, R. Veillon, N. Isambert, T. Nagy, V. Muller, B. Medgyasszay, D. Rodriguez-Abreu, A. Fernandez, A. Puaud, S. Bensfia, N. Yang, A. Spira |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S65-S66 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.02.084 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|